Dr. Fleming is a member of the Fred Hutchinson Cancer Research Center in Seattle and former director of the Statistical Center for HIV/AIDS Prevention Trial Network for the National Institute of Allergy and Infectious Diseases. He has authored or coauthored several books and more than 250 research articles in peer-reviewed journals, many regarding the development of state-of-the-art-methods for the design, conduct and analysis of clinical trials, and others reporting the results of landmark trials including the 2011 publication in the New England Journal of Medicine on prevention of HIV transmission. This research, on which he was senior author, was recognized by Science Magazine to be the scientific “Breakthrough of the Year.”
Dr. Fleming has chaired or served on data monitoring committees for more than 100 clinical trials. He is a special government employee for the U.S. Federal Drug Administration (FDA), and for more than 25 years has served as a regular member of several FDA advisory committees and as an invited voting member on more than 100 occasions. He is the recipient of the FDA Commissioner’s Special Citation Award for Extraordinary Contribution to the Agency.
At the University of Washington, Dr. Fleming received the Outstanding Teaching Award in the School of Public Health, was the 2009 Distinguished Lecturer for the School of Public Health, and in 2011 was the Ross Prentice Endowed Professor of Biostatistical Collaboration. He was the 2007 Greenberg Lecturer at the University of North Carolina at Chapel Hill, and in 2012 was elected to membership in the Institute of Medicine of the National Academies.
